Lewis Rowland Roberts, MB, ChB, PhD

Professor

  • 13173 Citations
  • 60 h-Index
1991 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Hepatocellular Carcinoma Medicine & Life Sciences
Cholangiocarcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Liver Neoplasms Medicine & Life Sciences
Liver Medicine & Life Sciences
Survival Medicine & Life Sciences
Sulfatases Medicine & Life Sciences
Fibrosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1999 2020

Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)

Roberts, L. R., Hassan, M. M., Amos, C. & Donghui, L.

National Institutes of Health

4/10/153/31/20

Project: Research project

Genome-Wide Association Study
Hepatocellular Carcinoma
Hepacivirus
Chronic Hepatitis C
Virus Diseases
Tumor Microenvironment
Sulfatases
Hepatocellular Carcinoma
Wnt Signaling Pathway
Intercellular Signaling Peptides and Proteins
Tumor Microenvironment
Hepatocellular Carcinoma
Heparan Sulfate Proteoglycans
Platelet-Derived Growth Factor
Transforming Growth Factors
Chronic Hepatitis B
Hepatitis B e Antigens
Hepatocellular Carcinoma
Liver Diseases
End Stage Liver Disease

Research Output 1991 2019

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R. & Heimbach, J. K., Jan 1 2019, In : Clinical Liver Disease. 13, 1, 1 p.

Research output: Contribution to journalEditorial

Hepatocellular Carcinoma

Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy

Dhanasekaran, R., Nault, J. C., Roberts, L. R. & Zucman-Rossi, J., Jan 1 2019, In : Gastroenterology. 156, 2, p. 492-509 18 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Medicine
Liver Neoplasms
Aflatoxins
Fatty Liver

Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation

Kisiel, J. B., Dukek, B. A., V.S.R. Kanipakam, R., Ghoz, H. M., Yab, T. C., Berger, C. K., Taylor, W. R., Foote, P. H., Giama, N. H., Onyirioha, K., Abdallah, M. A., Burger, K. N., Slettedahl, S. W., Mahoney, D. W., Smyrk, T. C., Lewis, J. T., Giakoumopoulos, M., Allawi, H. T., Lidgard, G. P., Roberts, L. R. & 1 othersAhlquist, D. A., Jan 1 2019, In : Hepatology.

Research output: Contribution to journalArticle

Genetic Markers
Hepatocellular Carcinoma
DNA
Area Under Curve
Homeobox Genes
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Metformin
Hepatocellular Carcinoma
Joints
Survival

Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis

Yadav, S., Xie, H., Bin-Riaz, I., Sharma, P., Durani, U., Goyal, G., Borah, B. J., Borad, M. J., Smoot, R. L., Roberts, L. R., Go, R. S., Mc Williams, R. R. & Mahipal, A., Jan 1 2019, In : European Journal of Surgical Oncology.

Research output: Contribution to journalArticle

Propensity Score
Cholangiocarcinoma
Adjuvant Chemotherapy
Drug Therapy
Survival